[1]
A. Jfri, R. Meltzer, and L. Guggina, “Runner Up: Incidence of Cutaneous Adverse Events with PI3K-Akt-mTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis”, J of Skin, vol. 6, no. 3, p. s39, May 2022.